# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-19-005883
Filing Date
2019-03-28
Accepted
2019-03-28 16:11:32
Documents
4
Period of Report
2019-05-14
Effectiveness Date
2019-03-28

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | bp18389x2_def14a.htm | DEF 14A | 1229317
2 |  | bp18389x2_proxycard01.jpg | GRAPHIC | 1135224
3 |  | bp18389x2_proxycard02.jpg | GRAPHIC | 910780
4 |  | davidbthomson_sig.jpg | GRAPHIC | 15437
| Complete submission text file | 0001140361-19-005883.txt |  | 3878130

Mailing Address 30930 RUSSELL RANCH ROAD SUITE 300 WESTLAKE VILLAGE CA 91362
Business Address 30930 RUSSELL RANCH ROAD SUITE 300 WESTLAKE VILLAGE CA 91362 818-661-5000
MANNKIND CORP (Filer) CIK: 0000899460 (see all company filings)

EIN.: 133607736 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-50865 | Film No.: 19712055
SIC: 2834 Pharmaceutical Preparations